Ketorolac + homatropine methyl bromide

Ketoprofen is a non-selective NSAID with IC50 of 0.5 μM and 2.33 μM for human recombinant COX-1 and COX-2, respectively.An inhibitor of Cox-1 and Cox-2.

Ketoprofen is a non-selective NSAID with IC50 of 0.5 μM and 2.33 μM for human recombinant COX-1 and COX-2, respectively.An inhibitor of Cox-1 and Cox-2.

Ketoprofen is a non-selective NSAID with IC50 of 0.5 μM and 2.33 μM for human recombinant COX-1 and COX-2, respectively.An inhibitor of Cox-1 and Cox-2.

Ketoprofen is a non-selective NSAID with IC50 of 0.5 μM and 2.33 μM for human recombinant COX-1 and COX-2, respectively.An inhibitor of Cox-1 and Cox-2.

A selective p38&alpha MAPK inhibitor (IC₅₀ = 26 nM in a cell-free assay) demonstrates anti-inflammatory activity in chronic disease models.

A selective p38&alpha MAPK inhibitor (IC₅₀ = 26 nM in a cell-free assay) demonstrates anti-inflammatory activity in chronic disease models.

A selective p38&alpha MAPK inhibitor (IC₅₀ = 26 nM in a cell-free assay) demonstrates anti-inflammatory activity in chronic disease models.

A selective p38&alpha MAPK inhibitor (IC₅₀ = 26 nM in a cell-free assay) demonstrates anti-inflammatory activity in chronic disease models.

A proposed anti-inflammatory EPA metabolite that has been shown to promote inflammatory resolution in numerous disease models, including experimental colitis, asthma, atherosclerosis, type 2 diabetes, and HSV-1-induced stromal keratitis.

Product Describtion:SB225002, a potent, selective and non-peptide CXCR2 antagonist, inhibits 125I-IL-8 binding to CXCR2 with an IC50 of 22 nM.